Market News (Page 41) - TendieTensor

Market News Page 41 of 277 • 6,903 articles

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

GlobeNewswire Inc. • Na

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

12/29/2025 08:00 AM • Kratos Defense & Security Solutions announced it has received approximately $30 million in contracts for air defense and C5ISR system military-grade custom hardware production. The company will perform work in secure manufacturing facilities, leveraging its expertise in missile, radar, counter-UAS, and other complex defense systems.

AAPL - Part of tech sector experiencing investment shifts, but no specific negative indicators mentioned
KTOS - The company secured $30 million in new defense contracts, demonstrating strong customer confidence and continued demand for its military-grade hardware production capabilities. Leadership statements emphasize the company's competitive advantages in delivering mission-critical systems on time and at scale, indicating healthy business momentum and market position.

#defense contracts #military hardware #air defense systems #C5ISR #national security #manufacturing #hypersonic systems #counter-UAS

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

GlobeNewswire Inc. • Na

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

12/29/2025 08:00 AM • Praxis Precision Medicines received FDA Breakthrough Therapy Designation for ulixacaltamide, a T-type calcium channel inhibitor for essential tremor treatment, based on positive Phase 3 Essential3 program results. The company plans to submit a New Drug Application (NDA) in early 2026 following a successful pre-NDA meeting with the FDA.

PRAX - The company received FDA Breakthrough Therapy Designation, which accelerates development and regulatory review. Positive Phase 3 trial results and successful pre-NDA alignment with FDA support faster advancement toward commercialization. The designation addresses a significant unmet medical need in a large patient population (7 million in the US), representing substantial commercial opportunity.

#Breakthrough Therapy Designation #ulixacaltamide #essential tremor #FDA approval #NDA submission #T-type calcium channels #Phase 3 clinical trial

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

GlobeNewswire Inc. • Not Specified

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

12/29/2025 08:00 AM • Reviva Pharmaceuticals Holdings, Inc. announced that its Founder, President, and CEO Laxminarayan Bhat will present at the Sachs 9th Annual Neuroscience Innovation Forum on January 11, 2026, in San Francisco. The late-stage biopharmaceutical company is developing therapies for CNS, inflammatory, and cardiometabolic diseases, with two main drug candidates: brilaroxazine (RP5063) and RP1208.

KLXY - Rising for five consecutive sessions, reflecting growing confidence in luxury brands
RVPH - The article is primarily a conference presentation announcement with standard corporate disclosure. While the company mentions ongoing FDA interactions and potential NDA submission timelines for brilaroxazine, the main content is promotional in nature. The regulatory update referenced suggests FDA requested additional Phase 3 data, which is neither particularly positive nor negative, representing a typical development pathway adjustment.

#Reviva Pharmaceuticals #brilaroxazine #RP5063 #RP1208 #CNS diseases #schizophrenia #FDA #NDA submission #Phase 3 trial #biopharmaceutical

BiomX Announces $3.0 Million Private Placement

GlobeNewswire Inc. • Biomx Inc.

BiomX Announces $3.0 Million Private Placement

12/29/2025 08:00 AM • BiomX Inc. announced a private placement financing of approximately $3.0 million gross proceeds through the issuance of Series Y Convertible Preferred Stock and warrants. The company plans to use net proceeds to assess opportunities for its bacteriophage programs, including BX011 for diabetic foot infections, and for general corporate purposes while evaluating strategic alternatives.

DECK - Included in top luxury index, indicating potential for growth in high-end market
PHGE - The company secured $3.0 million in funding, which is positive for liquidity. However, the relatively modest funding amount, ongoing evaluation of strategic alternatives, and discontinuation of the BX004 CF trial (mentioned in supplementary content) suggest financial constraints and development challenges. The neutral sentiment reflects both the capital raise and underlying operational uncertainties.

#private placement #convertible preferred stock #warrants #phage therapy #BX011 #financing #strategic alternatives

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

GlobeNewswire Inc. • Theriva Biologics, Inc.

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

12/29/2025 08:00 AM • Theriva Biologics received favorable scientific advice from the European Medicines Agency (EMA) on the design of a Phase 3 clinical trial for VCN-01 in combination with gemcitabine/nab-paclitaxel for treating metastatic pancreatic ductal adenocarcinoma (PDAC). The EMA approved the proposed trial design, sample size, and adaptive design elements. The company plans to meet with the FDA in H1 2026 for a multinational Phase 3 trial and has cash runway through Q1 2027.

LRLCY - Part of top luxury index holdings, positioned to benefit from premium consumer trends
TOVX - The company received favorable regulatory guidance from the EMA on its lead candidate VCN-01, with approval of the Phase 3 trial design including sample size and dosing regimen. The EMA's recognition of improved survival outcomes with multiple VCN-01 doses and acceptance of repeated dosing cycles strengthens the development pathway. Planned FDA meeting in H1 2026 and adequate cash runway through Q1 2027 support near-term progress on pivotal trials.

#VCN-01 #pancreatic cancer #Phase 3 trial #EMA approval #gemcitabine/nab-paclitaxel #oncolytic adenovirus #retinoblastoma #clinical development

CCH Holdings Projects Multiple Acquisitions, New Business Ventures and International Expansion in 2026

GlobeNewswire Inc. • Cch Holdings Ltd

CCH Holdings Projects Multiple Acquisitions, New Business Ventures and International Expansion in 2026

12/29/2025 08:00 AM • CCH Holdings Ltd, a Malaysia-based specialty hotpot restaurant chain, announced plans for 2026 including acquisitions of multiple Malaysian restaurant chains, new business ventures in Malaysia, and expansion into the U.S. and Africa markets. The company aims to leverage these developments to drive growth and maximize shareholder value.

CFRUY - Jewelry spending accelerated to 16%, indicating strong luxury market performance
CCHH - The company announced ambitious growth plans including multiple acquisitions, new business ventures, and international expansion to the U.S. and Africa. These strategic initiatives signal management confidence and growth trajectory. However, the sentiment is tempered by the safe harbor statement acknowledging that these plans 'might not materialize as planned or materialize at all,' introducing execution risk.

#acquisitions #international expansion #Malaysia #hotpot restaurants #business ventures #U.S. expansion #Africa expansion

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. • Na

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

12/29/2025 08:00 AM • Inspire Medical Systems announced that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at 12:45 p.m. ET. The presentation will be available via live webcast and replay.

INSP - The announcement is a routine corporate event notification regarding a scheduled investor conference presentation. It contains no material business updates, financial performance indicators, or strategic developments that would warrant positive or negative sentiment. It is a standard disclosure of participation in an industry conference.

#J.P. Morgan Healthcare Conference #investor presentation #obstructive sleep apnea #neurostimulation technology #medical device

Datavault AI Inc. Announces Proposed Dividend of Warrants

Benzinga • Globe Newswire

Datavault AI Inc. Announces Proposed Dividend of Warrants

12/29/2025 07:55 AM • Datavault AI (NASDAQ: DVLT) announced a proposed special dividend distribution of warrants to common stockholders. The record date is set for January 7, 2026, with eligible shareholders receiving one warrant for every 60 shares owned. The warrants will have a $5.00 strike price, be exercisable for one year, and require holders to own at least one Dream Bowl Meme Coin II token to exercise them.

CSCO - Mentioned as lifting outlook, suggesting potential positive market performance
DVLT - The announcement of a warrant dividend is a corporate action that could be viewed positively as shareholder value distribution, but the requirement to hold a meme coin token (Dream Bowl Meme Coin II) to exercise warrants introduces significant uncertainty and risk. The conditional nature of the dividend, board's ability to revoke it, and the speculative nature of the meme coin requirement create a mixed outlook that warrants a neutral stance rather than clearly positive or negative.

#warrant dividend #special dividend #strike price #record date #digital wallet requirement #meme coin token

Benzinga • Lekha Gupta

Why Is Brand Engagement Network Stock Gaining Monday?

12/29/2025 07:48 AM • Brand Engagement Network (NASDAQ: BNAI) stock rose 20% in premarket trading Monday following the finalization of a Vendor Services Project Agreement with a global advertising agency to develop an AI engagement solution for a top-10 pharmaceutical company. The deal includes $250k in development revenue in Q4 2025 and ongoing monthly licensing fees starting Q1 2026. The company also reported a $2.5 million decrease in total liabilities through settlements and debt-to-equity conversions.

DIA - Article highlights record-breaking performance and potential for continued gains
BNAI - Stock gained 20% on news of a significant vendor services agreement with a major advertising agency for a top-10 pharmaceutical company, generating $250k in Q4 2025 revenue and recurring licensing fees starting Q1 2026. Additional positive factors include debt reduction of $2.5 million and expansion into Mexico with Skye Salud launch, demonstrating growing adoption of the company's AI technology and improving financial position.

#Brand Engagement Network #AI engagement solution #pharmaceutical #licensing fees #debt reduction #Mexico expansion #stock gain

Is the Current Price Offering a Rare Opportunity to Buy Ford Stock?

The Motley Fool • Neil Patel

Is the Current Price Offering a Rare Opportunity to Buy Ford Stock?

12/29/2025 07:32 AM • Ford Motor Company trades at an attractive valuation with a forward P/E of 9.5 and 4.5% dividend yield, up 35% year-to-date. However, the analyst argues this is not a rare buying opportunity, citing Ford's decade-long underperformance (64% total return vs. market), low growth prospects, compressed margins, high capital expenditure needs, intense competition, and cyclical demand sensitivity as reasons to avoid the stock.

F - Despite cheap valuation and attractive dividend yield, the analyst explicitly states this is not a rare opportunity worth taking. Ford faces structural challenges including low growth prospects, compressed profit margins, high capital requirements, intense competition, and cyclical demand sensitivity. The stock's 10-year underperformance (64% return vs. market outperformance) and recent $19.5 billion EV segment writedown further support a negative outlook.

#Ford stock valuation #dividend yield #automotive industry #underperformance #EV segment writedown #capital expenditure

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

GlobeNewswire Inc. • Na

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

12/29/2025 06:59 AM • Dimensional Fund Advisors Ltd. has disclosed a 5.70% interest in American Axle & Manufacturing Holdings Inc., comprising 6,764,257 USD 0.01 common shares as of December 24, 2025. The disclosure includes a recent purchase of 5,525 shares at $6.4309 per share and a transfer in of 3,325 shares. Dimensional also made concurrent disclosures regarding Dowlais Group PLC in relation to the same offer.

AXL - This is a regulatory disclosure of an investment position. The 5.70% stake and recent share purchases indicate investor confidence, but the disclosure itself is a factual regulatory filing without inherent positive or negative implications. The sentiment is neutral as it represents standard market activity and transparency.

#Form 8.3 #takeover disclosure #stake disclosure #investment position #relevant securities

Form 8.3 - [IQE PLC - 24 12 2025] - (CGAML)

GlobeNewswire Inc. • Na

Form 8.3 - [IQE PLC - 24 12 2025] - (CGAML)

12/29/2025 06:58 AM • Canaccord Genuity Asset Management Limited disclosed a 2.43% interest in IQE PLC as of December 24, 2025, holding 23,755,000 ordinary shares. The disclosure also noted a sale of 100,000 shares at 5.006p per share. This represents a public opening position disclosure under Takeover Code Rule 8.3.

IQEPY - The disclosure is a regulatory filing indicating a significant shareholding position (2.43%) by an asset manager. While the accompanying share sale of 100,000 shares could suggest slight profit-taking or portfolio adjustment, the overall disclosure is factual and regulatory in nature with no clear positive or negative implications for the company's fundamentals or prospects.

#IQE PLC #Canaccord Genuity Asset Management #stake disclosure #Form 8.3 #Takeover Code #share sale

DHT Holdings, Inc. announces the sale of two VLCCs

GlobeNewswire Inc. • Na

DHT Holdings, Inc. announces the sale of two VLCCs

12/29/2025 06:57 AM • DHT Holdings announced the sale of two crude oil tankers (DHT China and DHT Europe) for a combined $101.6 million. After debt repayment of $5.6 million, the company expects net cash proceeds of approximately $95.0 million and will record gains of $30.4 million and $29.7 million respectively from the sales. Both vessels, built in 2007, are expected to be delivered in Q1 2026.

CMCSA - Company is investing $4 billion in California technology infrastructure, expanding rural internet access, and supporting local community digital opportunities through grants and library contributions
DHT - The company is generating significant net cash proceeds ($95 million) and substantial gains ($60.1 million combined) from the asset sale. This demonstrates effective capital allocation and provides liquidity for potential dividends, debt reduction, or share buybacks, which aligns with the company's stated disciplined capital allocation strategy.

#vessel sale #crude oil tanker #VLCC #capital allocation #cash proceeds #asset disposal

YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST

GlobeNewswire Inc. • Yieldmax® Etfs

YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST

12/29/2025 06:55 AM • YieldMax® announced weekly distributions for three newly launched ETFs tracking MSTR, NVDA, and TSLA with target 25% annual income levels. The distributions, effective December 30-31, 2025, ranged from $0.2013 to $0.2679 per share with distribution rates between 89.68% and 95.70%. However, the funds carry significant risks including call writing strategy limitations, counterparty risk, and no guarantee of future distributions.

SPGI - Mentioned as the financial arm that remained public after McGraw Hill went private in 2013
NVDA - NVDA is referenced as the underlying asset for the NVIT ETF with a weekly distribution of $0.2427 and 95.70% distribution rate. Sentiment is neutral as the announcement focuses on ETF mechanics and distribution details rather than NVIDIA's operational performance or market position.

#ETF distributions #income strategy #call writing #options trading #weekly distributions #new fund launch

Epoxy Resin Market Size Worth USD 21.22 Bn by 2035 Driven by EV Growth, Renewable Energy, and Infrastructure Development

GlobeNewswire Inc. • Precedence Research

Epoxy Resin Market Size Worth USD 21.22 Bn by 2035 Driven by EV Growth, Renewable Energy, and Infrastructure Development

12/29/2025 06:55 AM • The global epoxy resin market is projected to grow from USD 12.33 billion in 2025 to USD 21.22 billion by 2035, with a CAGR of 5.58%. Growth is driven by electric vehicle expansion, renewable energy development, and infrastructure projects. Asia Pacific dominates with 59.81% market share, while North America shows fastest growth. Key applications include paints/coatings (41.50% share) and adhesives/sealants.

MMM - Listed as a major diversified chemical player and significant global epoxy resin supplier with strong brand and broad product portfolio across automotive, electronics, and industrial applications.

#epoxy resin #market growth #electric vehicles #renewable energy #infrastructure #Asia Pacific #composites #coatings #adhesives

Heineken N.V. reports the progress of transactions under its current share buyback programme

GlobeNewswire Inc. • Na

Heineken N.V. reports the progress of transactions under its current share buyback programme

12/29/2025 06:00 AM • Heineken N.V. announced progress on its €1.5 billion share buyback programme as of December 26, 2025. The company repurchased 109,494 shares on exchange at an average price of €68.48 and 103,476 shares from Heineken Holding N.V. during the week of December 22-26. To date, 9,845,033 shares have been repurchased for a total consideration of €700,433,308, representing approximately 93% completion of the first €750 million tranche.

HMKIY - Develops advanced cup solutions with bio-based coatings designed for recyclability and compostability
HEINY - The company is executing a substantial €1.5 billion share buyback programme, demonstrating confidence in its valuation and commitment to returning capital to shareholders. The programme is progressing well with approximately 93% of the first tranche completed, indicating strong execution and financial health.

#share buyback #share repurchase #capital allocation #shareholder returns #Heineken Holding N.V. #EURONEXT #OTCQX

Datavault AI Inc. Announces Board Approval of Dividend of Dream Bowl Meme Coin II to All Eligible Record Equity Holders of Datavault AI

GlobeNewswire Inc. • Na

Datavault AI Inc. Announces Board Approval of Dividend of Dream Bowl Meme Coin II to All Eligible Record Equity Holders of Datavault AI

12/29/2025 05:57 AM • Datavault AI announced board approval to distribute Dream Bowl Meme Coin II tokens to eligible shareholders as a dividend, with a record date of January 7, 2026. The distribution is part of a strategic partnership with Dream Bowl XIV and NFL Alumni Health to support player health and wellness initiatives. The company emphasizes that the meme coin is a digital collectible for entertainment purposes only and does not represent equity, voting rights, or investment value.

DVLT - While the company announces a strategic partnership and shareholder dividend, the article heavily emphasizes disclaimers that the meme coin has no investment value, no equity rights, and may not maintain any value. The board retains the right to revoke the distribution at any time. These caveats and the speculative nature of meme coin distributions create a neutral outlook despite the positive framing of the announcement.

#dividend distribution #meme coin #tokenization #digital collectible #Dream Bowl XIV #NFL Alumni Health #shareholder value #blockchain #Web 3.0

SLM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that SLM Corporation a/k/a Sallie Mae Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Robbins Geller Rudman & Dowd Llp

SLM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that SLM Corporation a/k/a Sallie Mae Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

12/29/2025 05:55 AM • A class action lawsuit has been filed against SLM Corporation (Sallie Mae) alleging the company made false statements about early-stage delinquencies in its private education loan portfolio and overstated the effectiveness of its loss mitigation programs. The lawsuit was triggered after TD Cowen reported July 2025 delinquencies were up 49 basis points, contradicting management's assurances about normal seasonal trends. SLM's stock fell approximately 8% following the disclosure.

HUBS - Mentioned as an integration platform without specific commentary
SLM - The company is accused of making false and misleading statements regarding delinquency rates and the effectiveness of loss mitigation programs. A significant discrepancy between management's claims and actual delinquency data led to an 8% stock price decline and triggered a securities class action lawsuit.

#class action lawsuit #securities fraud #delinquency rates #private education loans #misstatement #lead plaintiff

Stock Market Today: Dow Futures Rise, S&P 500, Nasdaq Slip Ahead Of New Year's Week—Target, Coupang, Taiwan Semiconductor In Focus

Benzinga • Rishabh Mishra

Stock Market Today: Dow Futures Rise, S&P 500, Nasdaq Slip Ahead Of New Year's Week—Target, Coupang, Taiwan Semiconductor In Focus

12/29/2025 05:44 AM • U.S. stock futures showed mixed performance on Monday with the Dow rising 0.03% while S&P 500 and Nasdaq 100 declined 0.22% and 0.42% respectively. The market faces a light week with New Year's Day closure on Thursday. Key movers include Target (activist investor stake), Coupang (data breach settlement), Taiwan Semiconductor (earthquake concerns), Bolt Projects (strong revenue growth), and Sable Offshore (pipeline lawsuit). Treasury yields held steady at 4.11% (10-year) and 3.47% (2-year), with markets pricing an 82.8% probability of unchanged Fed rates in January.

TGT - Activist investor Toms Capital Investment Management made a significant investment in Target, signaling confidence in the company's potential. Stock up 0.11% in premarket trading.

#stock market #futures #S&P 500 #Nasdaq #activist investor #data breach settlement #earthquake #Federal Reserve #Treasury yields #geopolitics

Asia Pacific Alcoholic Beverages Sponsorship in Sports Analysis Report 2025: CUB Dominates APAC Sponsorship Landscape with Largest Annual Spend

GlobeNewswire Inc. • Researchandmarkets.Com

Asia Pacific Alcoholic Beverages Sponsorship in Sports Analysis Report 2025: CUB Dominates APAC Sponsorship Landscape with Largest Annual Spend

12/29/2025 04:49 AM • Carlton and United Breweries (CUB) leads the APAC alcoholic beverages sports sponsorship market with the largest annual spend in 2025, anchored by an $8 million annual deal with the Australian Football League. Heineken ranks second in spending with its F1 Chinese Grand Prix title sponsorship, while Asahi Breweries holds the fifth position with $4.94 million in annual spend, including a $2.50 million Australian Open partnership.

TMUSI - Strong Q3 earnings with 9% revenue growth, record customer additions, raised forward guidance, low P/E ratio of 20, and HSBC analyst upgrade to Buy with a $285 price target indicating potential 40% upside
HKHHY - Heineken ranks second in annual sponsorship spend across APAC and holds the second-largest deal as title sponsor of the F1 Chinese Grand Prix, a high-profile international event that enhances brand prestige.

#alcoholic beverages #sports sponsorship #APAC region #AFL #NRL #Formula 1 #Australian Open #brand partnerships

GlobeNewswire Inc. • Na

Form 8.5 (EPT/RI) - Greencore Group Plc

12/29/2025 04:46 AM • Shore Capital Stockbrokers Ltd, an exempt principal trader with recognised intermediary status, has disclosed public dealing in Greencore Group Plc securities on 24 December 2025. The disclosure shows purchases of 2,296 ordinary shares at 252.25p and sales of 18,000 ordinary shares at prices between 251p-252p. No indemnity arrangements or derivative agreements were reported.

TMUSL - Strong Q3 earnings with 9% revenue growth, record customer additions, raised forward guidance, low P/E ratio of 20, and HSBC analyst upgrade to Buy with a $285 price target indicating potential 40% upside
GNCGY - The disclosure is a routine regulatory filing documenting client-serving trading activity. The net position shows significant sales (18,000 shares) relative to purchases (2,296 shares), but this reflects normal market-making activity by an intermediary rather than indicating positive or negative sentiment about the company's prospects.

#Form 8.5 #Takeover Code #exempt principal trader #public dealing disclosure #securities trading #recognised intermediary

Women's Rugby World Cup Post Event Business Analysis Report 2025: Sponsorship Revenue Reaches $14.7 Million, Asahi Breweries and Capgemini Lead With $2.5 Million Annual Deals

GlobeNewswire Inc. • Researchandmarkets.Com

Women's Rugby World Cup Post Event Business Analysis Report 2025: Sponsorship Revenue Reaches $14.7 Million, Asahi Breweries and Capgemini Lead With $2.5 Million Annual Deals

12/29/2025 04:43 AM • The 2025 Women's Rugby World Cup achieved record viewership of 5.8 million for the final and generated $14.7 million in sponsorship revenue from 22 deals. Asahi Breweries and Capgemini led sponsorships with $2.5 million annual deals each. The tournament sold over 440,000 tickets with the final drawing 81,885 spectators, demonstrating strong commercial appeal and female market engagement.

TMUSZ - Strong Q3 earnings with 9% revenue growth, record customer additions, raised forward guidance, low P/E ratio of 20, and HSBC analyst upgrade to Buy with a $285 price target indicating potential 40% upside
CGEMY - Matched Asahi's $2.5 million annual sponsorship deal as worldwide partner, demonstrating commitment to women's sports and gaining association with a record-breaking, high-engagement sporting event.

#Women's Rugby World Cup 2025 #sponsorship revenue #viewership records #ticket sales #female sports engagement #broadcasting

Update on Construction of Calcatreu Project

GlobeNewswire Inc. • Na

Update on Construction of Calcatreu Project

12/29/2025 04:41 AM • Patagonia Gold Corp. announced significant progress on its Calcatreu gold-silver project in Rio Negro, Argentina. Construction commenced in Q1 2025 with mining activities beginning in August 2025. The company expects to commence first leaching in Q1 2026 and has completed key infrastructure including explosives storage, chemical facilities, and a 192-person capacity camp. The project contains 9.84 million tonnes of measured and indicated mineral resources with 669,000 ounces of gold and 6.3 million ounces of silver.

HGLD - The company is demonstrating strong operational progress with mining activities commenced, key infrastructure completed ahead of schedule, and first leaching expected in Q1 2026. Successful recruitment of 135 employees, positive relationships with local authorities, and completion of critical facilities (explosives storage, chemical storage, leach pad) indicate the project is advancing well toward production. The substantial mineral resource base (669k oz gold, 6.3M oz silver) and on-track timeline support positive momentum.

#Calcatreu project #gold mining #silver mining #Argentina #Rio Negro Province #construction progress #mineral resources #leaching operations #epithermal gold system

UK Wealth Management Industry Report 2025: Investor Insight, Resident Savings and Investments, Digital Disruptors, Recent Deals

GlobeNewswire Inc. • Researchandmarkets.Com

UK Wealth Management Industry Report 2025: Investor Insight, Resident Savings and Investments, Digital Disruptors, Recent Deals

12/29/2025 04:39 AM • A new report on the UK wealth management market reveals that the affluent segment (16.1% of population) holds 66.3% of onshore liquid assets, with deposits comprising nearly half of retail savings portfolios. The market is forecast to grow at a 2.4% CAGR through 2029, driven by deposit growth at 3.1% CAGR. Bank advisors remain the primary investment channel, while digital disruptors and recent M&A activity are reshaping the competitive landscape.

SEGG - Mentioned as part of SEGG Media's portfolio but no specific actions or changes highlighted
LYG - As a major UK bank with significant advisor networks, Lloyds is well-positioned to benefit from the report's finding that bank advisors remain the most popular investment channel across all wealth segments.

#UK wealth management #affluent segment #liquid assets #deposits #retail savings #HNW individuals #digital disruptors #investment channels

Asia Pacific Technology, Media, & Telecom Sponsorship in Sport Analysis Report 2025: Key Opportunities Include Team Partnerships, with Tech Companies Collaborating with Soccer Clubs

GlobeNewswire Inc. • Researchandmarkets.Com

Asia Pacific Technology, Media, & Telecom Sponsorship in Sport Analysis Report 2025: Key Opportunities Include Team Partnerships, with Tech Companies Collaborating with Soccer Clubs

12/29/2025 04:32 AM • Soccer dominates APAC sports sponsorship with 47% of regional deal volume. Team partnerships lead with 436 deals worth $157.18 million annually. Jio emerges as the most active brand with nine IPL team deals, followed by J:COM and TCL with eight deals each. Asian-based companies dominate both spending and deal volume across the region.

JOCM - Ranked second in deal volume with eight active deals, indicating significant sponsorship activity and market participation in APAC sports.

#APAC sponsorship #soccer partnerships #tech companies #team sponsorships #esports #sports marketing